BRAF and colorectal carcinoma: Another proteomic study showed that mutant KRAS and BRAF in CRC cell lines could impact multiple aspects of metabolism, including glycolysis, phosphoserine biosynthesis, glutamine metabolism, and the non-oxidative pentose phosphate pathway, by modulating the expression of corresponding proteins/enzymes (Hutton et al., 2016).